Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CYLD Antikörper

CYLD Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal unconjugated
Produktnummer ABIN7637627
  • Target Alle CYLD Antikörper anzeigen
    CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
    Reaktivität
    • 44
    • 22
    • 17
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 38
    • 6
    • 1
    Maus
    Klonalität
    • 39
    • 6
    Monoklonal
    Konjugat
    • 21
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CYLD Antikörper ist unkonjugiert
    Applikation
    • 30
    • 14
    • 8
    • 5
    • 4
    • 4
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Monoclonal Antibody to Cylindromatosis (CYLD)
    Spezifität
    The antibody is a mouse monoclonal antibody raised against CYLD. It has been selected for its ability to recognize CYLD in immunohistochemical staining and western blotting.
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Top Product
    Discover our top product CYLD Primärantikörper
  • Applikationshinweise
    Western blotting: 0.2-2 μg/mL,1:500-5000 Immunohistochemistry: 5-20 μg/mL,1:50-200 Immunocytochemistry: 5-20 μg/mL,1:50-200 Optimal working dilutions must be determined by end user.
    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
  • Target
    CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
    Andere Bezeichnung
    CYLD (CYLD Produkte)
    Hintergrund
    CDMT, CYLD1, CYLDI, EAC, USPL2, Turban Tumor Syndrome, Ubiquitin Carboxyl-Terminal Hydrolase CYLD, Ubiquitin Specific Peptidase Like 2, Deubiquitinating enzyme CYLD
    UniProt
    Q9NQC7
    Pathways
    Apoptose, Activation of Innate immune Response
Sie sind hier:
Chat with us!